Molecular Imaging of Primary Amyloid Cardiomyopathy
A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 171 participants.
Also called NCT02641145
- Study
- In this atlas
Overview
- Design
- Interventional study; non-randomized; no masking; primary purpose diagnostic
- Phase
- Not applicable
- Enrolled
- 171 participants
- Sponsor
- Registry
-
NCT02641145
-
- Start date
- (registry gives no type)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States
- Registry status
- Recruiting
Technical summary
Registry record NCT02641145. Non-randomized; no masking; primary purpose diagnostic. Start 2016-04-01 (registry gives no type); primary completion 2027-12-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Molecular Imaging of Primary Amyloid Cardiomyopathy
- Acronym
- MICA
- Condition
- Amyloidosis, Primary
- Condition
- Cardiomyopathy
- Intervention (Radiation)
- F-18 florbetapir/C-11 acetate PET
- Intervention (Device)
- MRI
- Intervention (Radiation)
- N-13 ammonia PET
- Lead sponsor
- Brigham and Women's Hospital
- Collaborator
- National Institutes of Health (NIH)
- Collaborator
- National Heart, Lung, and Blood Institute (NHLBI)
- Collaborator
- American Heart Association
Record details
- Record id
cardio:ct-nct02641145- Content hash
8aec755669cc17e5b3c4b9e9953a996ecad36b5f1d929474825f8c2bd6b1adc2